Skip to main content
. 2021 Aug 12;12:709861. doi: 10.3389/fimmu.2021.709861

Table 4.

Adverse events.

Control (n = 16) Foralumab/Dexa (N = 11) Foralumab (n = 12)
Headache 1 0 3
Burning in the nostril 0 0 1
Retrosternal pain 0 2 0
Pustular Lesions and Itching in cervical area 0 0 1
Dysuria 1 0 0
Tachycardia (anxiety) 0 1 0
Insomnia 0 0 1

The incidence and severity of adverse events was determined according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0. Dexa= Dexamethasone.